chr16-67435830-C-A

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000196.4(HSD11B2):​c.468C>A​(p.Thr156=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0513 in 1,613,970 control chromosomes in the GnomAD database, including 3,250 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T156T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.084 ( 873 hom., cov: 32)
Exomes 𝑓: 0.048 ( 2377 hom. )

Consequence

HSD11B2
NM_000196.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.28
Variant links:
Genes affected
HSD11B2 (HGNC:5209): (hydroxysteroid 11-beta dehydrogenase 2) There are at least two isozymes of the corticosteroid 11-beta-dehydrogenase, a microsomal enzyme complex responsible for the interconversion of cortisol and cortisone. The type I isozyme has both 11-beta-dehydrogenase (cortisol to cortisone) and 11-oxoreductase (cortisone to cortisol) activities. The type II isozyme, encoded by this gene, has only 11-beta-dehydrogenase activity. In aldosterone-selective epithelial tissues such as the kidney, the type II isozyme catalyzes the glucocorticoid cortisol to the inactive metabolite cortisone, thus preventing illicit activation of the mineralocorticoid receptor. In tissues that do not express the mineralocorticoid receptor, such as the placenta and testis, it protects cells from the growth-inhibiting and/or pro-apoptotic effects of cortisol, particularly during embryonic development. Mutations in this gene cause the syndrome of apparent mineralocorticoid excess and hypertension. [provided by RefSeq, Feb 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 16-67435830-C-A is Benign according to our data. Variant chr16-67435830-C-A is described in ClinVar as [Benign]. Clinvar id is 586028.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-67435830-C-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.28 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.187 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HSD11B2NM_000196.4 linkuse as main transcriptc.468C>A p.Thr156= synonymous_variant 2/5 ENST00000326152.6
HSD11B2XM_047434048.1 linkuse as main transcriptc.156C>A p.Thr52= synonymous_variant 3/6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HSD11B2ENST00000326152.6 linkuse as main transcriptc.468C>A p.Thr156= synonymous_variant 2/51 NM_000196.4 P1
HSD11B2ENST00000567684.2 linkuse as main transcriptn.331C>A non_coding_transcript_exon_variant 2/43
HSD11B2ENST00000566606.1 linkuse as main transcriptc.*269C>A 3_prime_UTR_variant, NMD_transcript_variant 2/35

Frequencies

GnomAD3 genomes
AF:
0.0841
AC:
12787
AN:
152124
Hom.:
870
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.191
Gnomad AMI
AF:
0.0592
Gnomad AMR
AF:
0.0562
Gnomad ASJ
AF:
0.0576
Gnomad EAS
AF:
0.00385
Gnomad SAS
AF:
0.0712
Gnomad FIN
AF:
0.0360
Gnomad MID
AF:
0.177
Gnomad NFE
AF:
0.0413
Gnomad OTH
AF:
0.0813
GnomAD3 exomes
AF:
0.0542
AC:
13602
AN:
250788
Hom.:
596
AF XY:
0.0543
AC XY:
7365
AN XY:
135644
show subpopulations
Gnomad AFR exome
AF:
0.193
Gnomad AMR exome
AF:
0.0363
Gnomad ASJ exome
AF:
0.0616
Gnomad EAS exome
AF:
0.00250
Gnomad SAS exome
AF:
0.0812
Gnomad FIN exome
AF:
0.0362
Gnomad NFE exome
AF:
0.0439
Gnomad OTH exome
AF:
0.0526
GnomAD4 exome
AF:
0.0479
AC:
69959
AN:
1461728
Hom.:
2377
Cov.:
35
AF XY:
0.0482
AC XY:
35083
AN XY:
727178
show subpopulations
Gnomad4 AFR exome
AF:
0.201
Gnomad4 AMR exome
AF:
0.0380
Gnomad4 ASJ exome
AF:
0.0629
Gnomad4 EAS exome
AF:
0.00166
Gnomad4 SAS exome
AF:
0.0762
Gnomad4 FIN exome
AF:
0.0405
Gnomad4 NFE exome
AF:
0.0421
Gnomad4 OTH exome
AF:
0.0594
GnomAD4 genome
AF:
0.0841
AC:
12801
AN:
152242
Hom.:
873
Cov.:
32
AF XY:
0.0825
AC XY:
6142
AN XY:
74452
show subpopulations
Gnomad4 AFR
AF:
0.191
Gnomad4 AMR
AF:
0.0562
Gnomad4 ASJ
AF:
0.0576
Gnomad4 EAS
AF:
0.00386
Gnomad4 SAS
AF:
0.0709
Gnomad4 FIN
AF:
0.0360
Gnomad4 NFE
AF:
0.0413
Gnomad4 OTH
AF:
0.0810
Alfa
AF:
0.0496
Hom.:
349
Bravo
AF:
0.0880
Asia WGS
AF:
0.0530
AC:
182
AN:
3478
EpiCase
AF:
0.0442
EpiControl
AF:
0.0484

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsAug 14, 2017- -
Benign, criteria provided, single submitterclinical testingGeneDxNov 22, 2019This variant is associated with the following publications: (PMID: 16109323) -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Apparent mineralocorticoid excess Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 10, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
5.9
DANN
Benign
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs5479; hg19: chr16-67469733; COSMIC: COSV52099280; COSMIC: COSV52099280; API